Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA
Published 2 months, 3 weeks ago
Description
FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision Medicine Group as Lundbeck partners with Eversana on AI-driven commercialization, and Adam Bartley examines how integrated GMP operating models are reshaping outsourced manufacturing.